|
When immune systems attack, Rigel Pharmaceuticals wants to be there. The drug discovery and development firm focuses its proprietary research and development efforts on three main areas: inflammatory and autoimmune diseases, cancer, and viral diseases. Drugs undergoing clinical trials include candidates for treating rheumatoid arthritis, blood disorders, and various types of cancer. The company frequently works in collaboration with larger pharmaceutical firms: It is partnering with Daiichi Sankyo, Johnson & Johnson, and Merck to develop cancer drugs and with Pfizer on treatments for asthma.
|
| | | Contact Information | |
Address: |
1180 Veterans Blvd.
South San Francisco, CA 94080
| | Phone: | 650-624-1100 | | Fax: | 650-624-1101 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 0.00 M | | Employees (2008): | 181 | | Employee Growth (1 yr): | 13.80% |
|
|
Key People
| | • |
Chairman, President, and CEO:
James M. Gower
| | • |
EVP and COO:
Raul R. Rodriguez
| | • |
VP and CFO:
Ryan D. Maynard
|
|
|
